These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The burden of non-melanoma skin cancers in Auckland, New Zealand. Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397 [TBL] [Abstract][Full Text] [Related]
3. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975 [TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas. Wan J; Dai H; Zhang X; Liu S; Lin Y; Somani AK; Xie J; Han J Genes Dis; 2021 Mar; 8(2):181-192. PubMed ID: 33997165 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of SOX2 in non-melanoma skin cancer. Abdou AG; Mostafa AF; Gafar S; Farag AGA J Cosmet Dermatol; 2022 Jun; 21(6):2623-2628. PubMed ID: 34496119 [TBL] [Abstract][Full Text] [Related]
6. Clinician's Ability to Identify Non-Melanoma Skin Cancer on 3D-Total Body Photography Sectors that Were Initially Identified during In-Person Skin Examination with Dermoscopy. Hobelsberger S; Steininger J; Laske J; Berndt K; Meier F; Beissert S; Gellrich FF Dermatology; 2024; 240(1):142-151. PubMed ID: 37931611 [TBL] [Abstract][Full Text] [Related]
7. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood. Bartoš V Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852 [TBL] [Abstract][Full Text] [Related]
8. Role of suprabasin, a new biomarker in squamous cell carcinoma and basal cell carcinoma. Ucer O; Kocaman N Tissue Cell; 2022 Oct; 78():101875. PubMed ID: 35930991 [TBL] [Abstract][Full Text] [Related]
10. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma. Nanz L; Keim U; Katalinic A; Meyer T; Garbe C; Leiter U Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339357 [TBL] [Abstract][Full Text] [Related]
12. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. Rogers HW; Weinstock MA; Feldman SR; Coldiron BM JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283 [TBL] [Abstract][Full Text] [Related]
13. Sun protection for preventing basal cell and squamous cell skin cancers. Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416 [No Abstract] [Full Text] [Related]
15. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11. Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239 [TBL] [Abstract][Full Text] [Related]
16. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. Iannacone MR; Wang W; Stockwell HG; O'Rourke K; Giuliano AR; Sondak VK; Messina JL; Roetzheim RG; Cherpelis BS; Fenske NA; Rollison DE BMC Cancer; 2012 Sep; 12():417. PubMed ID: 22994655 [TBL] [Abstract][Full Text] [Related]
17. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Plesko I; Severi G; Obsitníková A; Boyle P Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834 [TBL] [Abstract][Full Text] [Related]
18. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas. Abdou AG; Eldien MM; Elsakka D Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229 [TBL] [Abstract][Full Text] [Related]
19. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Marcil I; Stern RS Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165 [TBL] [Abstract][Full Text] [Related]
20. Non-melanoma skin cancer: new and future synthetic drug treatments. Amaral T; Garbe C Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]